[1] 周莉,张川莉,王凌云,等.lncRNA NEAT1在急性髓系白血病患者外周血中的表达及其与预后的关系[J].现代医学,2020,48(5):573-578.
[2] GALLOWAY A J R,SMITH D P,SAHASRABHOJANE P,et al.The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia[J].Cancer,2016,122(14):2186-2196.
[3] 郭文坚,黄河,何牧卿,等.共患病评分在急性髓系白血病患者化疗并发症中的判断研究[J].中华全科医学,2016,14(9):1501-1503.
[4] 陈月,陶善东,史玉叶,等.具有合并症的急性髓系白血病老年患者的临床特征及预后分析[J].东南大学学报(医学版),2019,38(4):618-623.
[5] 洪燕,马岳,徐涛,等.急性白血病患儿并发侵袭性真菌感染临床特征和危险因素分析[J].中华临床感染病杂志,2017,10(4):81-83.
[6] NOGUCHI T,NAGAO M,YAMAMOTO M,et al.Staphylococcus epidermidis,meningitis in the absence of a neurosurgical device secondary to catheter-related bloodstream infection:a case report and review of the literature[J].J Med Case Rep,2018,12(1):106-109.
[7] 闫侠芳,舒晓艳,刘静,等.40例老年急性髓系白血病诱导化疗的临床分析[J].空军医学杂志,2016,32(2):97-101.
[8] CHEN H,LIU S,LIU J,et al.Nosocomial co-transmission of avian influenza A(H7N9) and A(H1N1)pdm09 viruses between 2 patients with hematologic disorders[J].Emerg Infect Dis,2016,22(4):598-607.
[9] 宫本法,刘云涛,张广吉,等.泊沙康唑初级预防在急性髓系白血病化疗期间的作用[J].中华血液学杂志,2017,38(6):230-235.
[10] 袁萍,张睿,陈斗佳,等.急性髓系白血病诱导缓解期患者下呼吸道感染的危险因素分析[J].中华医院感染学杂志,2017,27(20):4637-4640.
[11] 邓黎黎,曾鹏云,马丽辉,等.急性髓系白血病诱导缓解期患者下呼吸道感染病原菌分布与相关因素分析[J].中华医院感染学杂志,2017,27(16):3647-3650.
[12] MATHIAS B,DELMAS A L,OZRAZGAT-BASLANTI T,et al.Human myeloid-derived suppressor cells are associated with chronic immune suppression after severe sepsis/septic shock[J].Ann Surg,2017,265(4):827-831.
[13] 陈琼,刘隽,唐勇,等.重组人粒细胞-巨噬细胞集落刺激因子联合复方氯己定治疗急性髓系白血病化疗后口腔黏膜炎的临床观察[J].世界临床药物,2017,11(8):535-538.
[14] MARTINS K A,DYE J M,BAVARI S.Considerations for the development of Zika virus vaccines[J].Vaccine,2016,34(33):3711-3715.
[15] 陈丽,祝洪明,李啸扬,等.初发APL患者接受ATRA+ATO±化疗早期死亡危险因素分析[J].临床血液学杂志,2016,5(3):366-370.
[16] 刘晨曦,魏辉,周春林,等.替加环素治疗急性白血病化疗后粒细胞缺乏患者血流感染1例[J].实用医学杂志,2016,32(8):1378. |